resource
MEMBERS ONLYAVMA market share estimator
JAVMA news
Vetsulin back on the market
Merck Animal Health announced in late April that Vetsulin is available again in the United States.
JAVMA news
Chlorpyrifos to be phased out of market
The US Environmental Protection Agency has changed the specifications for use of insecticides containing chlorpyrifos
JAVMA news
Euthanasia solution reentering market
Phone calls made May 30 by AVMA staff to a number of suppliers of dosage form euthanasia solution revealed that the product has been trickling in…
Marketing tools and client services
Save time with AVMA tools that help you communicate with clients in person and online.
Marketing your social media
Use as many of your existing client communication channels as possible to spread the word about your veterinary clinic's social media pages. Here's…
policy
Unapproved new animal drugs marketed as devices
The AVMA encourages increased enforcement in regulating the marketing of products represented as devices but appearing to be unapproved new animal…
Promotional marketing for National Pet Dental Health Month
Even with limited marketing resources, there are simple steps you can take to generate publicity and excitement for National Pet Dental Health Month…
JAVMA news
FTC pushes for more competition in pet medications market
The Federal Trade Commission released a report in May finding that veterinarians will continue to face increasing competition from nonveterinary…
JAVMA news
Program created to help researchers market their discoveries
The Texas A&M University College of Veterinary Medicine & Biomedical Sciences is getting $1.2 million to create a nationwide training program that…
JAVMA news
AVMA: Prioritize animal welfare, not marketing, in treatment decisions
AVMA leaders advocate against withholding any necessary medications from livestock, including on organic and antimicrobial-free farms.
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
JAVMA news
AASV: Sick pigs need aid, regardless of marketing plans
Pigs should receive care to prevent suffering even if that precludes sale of pork as antibiotic free, according to the American
JAVMA news
FIP drugs continue to show promise, while being sold on black market
Two antiviral drugs have shown promise for the treatment of cats with feline infectious peritonitis. Some desperate cat owners have turned to the…
Social media for veterinary clinics
Social media is an integral part of marketing. Whether you’re brand new to it or a long-time user, these tools will help you make the most of your…
JAVMA news
FDA extends comment period on unapproved animal drugs
The Food and Drug Administration is extending until April 19 the deadline for submitting comments on strategies to address categories of animal drug…
JAVMA news
Efforts to keep cisapride available meet dead end
Regulatory restrictions have prevented the AVMA from keeping open the channels of veterinary access to a human drug
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
Reports and statistics
Providing economic insights and market data, AVMA reports and data inform discussions on the most pressing issues facing veterinary medicine.
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
First new animal drug listed on MUMS Index
The Food and Drug Administration in March announced the first new animal drug granted to the Index of Legally Marketed Unapproved New Animal Drugs for…
AVMA news
Claims about meat, poultry products come under greater USDA scrutiny
The U.S. Department of Agriculture is stepping up efforts to ensure the veracity of claims about food animal products marketed as "free range" and…
JAVMA news
Heartworm treatment not available
Immiticide, the only heartworm adulticide on the U.S. market, was temporarily unavailable as of early August.
JAVMA news
Good news, bad news for equine practice owners
The market for equine veterinary services has changed fundamentally since the Great Recession.
JAVMA news
Bayer pulls Baytril
Bayer Corporation has stopped distribution of the antimicrobial enrofloxacin for poultry, which was marketed under the name Baytril